Posts with tag 2023

Sort by Latest
Public Procurement for Biological Medicines in Belgium: The Royal Decree of 13 September 2023 opens the door for compulsory tendering when biosimilars enter the market. Can virtue afford to flirt with legality?
Introduction The Royal Decree of September 13, 2023 (‘RD’), implementing Article 71bis, § 1, of the Belgian Act on Compulsory Health Care Insurance and Benefits (‘Wet betreffende de verplichte verzekering voor geneeskundige verzorging en uitkeringen’), which establishes specific regulations for public procurement concerning biological medicines, was published in the Belgian Official Gazette on September 22, 2023. The impact of this Royal Decree on the sector could be significant,...
September 27, 2023
7 min read
AI and the life sciences, navigating the complex legal...
Bird & Bird’s international life sciences and healthcare...
August 10, 2023
5 min read
EU Commission’s proposed changes to marketing authorisation...
This article is part of a series that covers the proposed...
August 9, 2023
6 min read
Reforming the European pharmaceutical legislation:...
This article is part of a series that covers the proposed...
August 7, 2023
5 min read
Code of practice introduced for holding cultivated meat tastings
Particularly in the Netherlands, developments in the field of cultivated meat have succeeded each other...
July 12, 2023
6 min read
Strengthened Environmental Risk Assessment requirements under the proposed new directive on medicinal products for human use
This article is part of a series that covers the proposed reforms to EU pharmaceutical legislation....
June 23, 2023
3 min read
Guide to EU and UK Pharmaceutical Regulatory Law 2023
Eighth Edition, Edited by Sally Shorthose The Guide to EU and UK Pharmaceutical Regulatory...
January 31, 2023
3 min read